Latanoprost/timolol

Latanoprost/timolol
Combination of
Latanoprost	Prostaglandin
Timolol	Beta blocker
Clinical data
Trade names	Xalacom
AHFS/Drugs.com	UK Drug Information
Routes of administration	Eye drops
Identifiers
CAS Number	852336-82-4
ATC code	S01ED51
PubChem	CID 56841581

Latanoprost/timolol (trade name Xalacom) is a combination drug used in glaucoma, consisting of latanoprost (increasing the outflow of aqueous fluid from the eyes (through the uveal-scleral tract^[1]) and timolol (a beta blocker decreasing the production of aqueous fluid).

References

↑ Patel SS, Spencer CM (1996). "Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension". Drugs Aging 9 (5): 363–378. doi:10.2165/00002512-199609050-00007. PMID 8922563.

Drugs used for glaucoma preparations and miosis (S01E)

Sympathomimetics

Parasympathomimetics

muscarinic	Aceclidine Pilocarpine

muscarinic/nicotinic	Acetylcholine Carbachol

Acetylcholinesterase inhibitors	Demecarium Ecothiopate Stigmine (Fluostigmine Neostigmine Physostigmine) Paraoxon

Carbonic anhydrase inhibitors/
(sulfonamides)

Beta blocking agents

Prostaglandin analogues (F_2α)

Other agents

This article is issued from Wikipedia - version of the Wednesday, May 14, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.